Saturday, January 23, 2021

Remdesivir not a Covid cure – WHO


Latest Stories

Hank Aaron, baseball’s one-time home run king, dies at 86

HOMERUN KING In this March 29, 2017, file photo, Hank Aaron looks at his new statue in Monument Garden...

PH logs 2,178 new Covid cases 

THE Philippines logged 2,178 new cases of the coronavirus disease 2019 (Covid-19) on Friday, pushing the total to 509,887,...

12 new cases of B117 Covid variant confirmed in Bontoc 

THE municipality of Bontoc, Mountain Province has confirmed that some of the specimens of coronavirus disease 2019 (Covid-19) cases...

Mariel Rodriguez denies rumor that Robin Padilla impregnated Mocha Uson

Contoversial starlet-turned-Presidential appointee laughs it off Actress-television host Mariel Rodriguez has dismissed rumors alleging her husband, action star Robin Padilla,...

Rocco Nacino marries Melissa Gohing on a Navy ship

Actor Rocco Nacino has finally tied the knot with volleyball star Melissa Gohing. The actor and Philippine Navy reservist tied...

BANGKOK: The antiviral drug remdesivir should not be used to treat Covid-19 patients no matter how ill they are as there is no evidence it works, the World Health Organization (WHO) said.

“The … panel found a lack of evidence that remdesivir improved outcomes that matter to patients such as reduced mortality, need for mechanical ventilation, time to clinical improvement, and others,” said the WHO’s Guideline Development Group (GDG) panel.

“Any beneficial effects of remdesivir, if they do exist, are likely to be small and the possibility of important harm remains,” said the panel.

The WHO recommendation, published in the British Medical Journal, was based on an evidence review that included data from four international randomized trials among more than 7,000 hospitalized patients.

After reviewing the evidence, the panel concluded that remdesivir has no meaningful effect on death rates or other important outcomes for patients.

“Especially given the costs and resource implications associated with remdesivir …the panel felt the responsibility should be on demonstrating evidence of efficacy, which is not established by the currently available data,” it said.

The antiviral is one of only two medicines currently authorized to treat Covid-19 patients across the world.

It has been approval for use in the United States, the European Union and other countries after initial research found it may shorten recovery time in some Covid-19 patients.

Made by the US company Gilead, remdesivir is extremely expensive and has to be given intravenously.

Gilead said last month that the drug had boosted its third quarter sales by about $900 million.



Today's Front Page